ATALANTA Trademark

Trademark Overview


On Monday, January 22, 2024, a trademark application was filed for ATALANTA with the United States Patent and Trademark Office. The USPTO has given the ATALANTA trademark a serial number of 98369396. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 11, 2025. This trademark is owned by Atalanta Therapeutics, Inc.. The ATALANTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurodegenerative diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of human diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurological diseases and disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of pain; Pharmaceutical preparations, namely, RNA therapeutics for the treatment diseases of the central nervous system
atalanta

General Information


Serial Number98369396
Word MarkATALANTA
Filing DateMonday, January 22, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, RNA therapeutics for the treatment of neurodegenerative diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of human diseases; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of neurological diseases and disorders; Pharmaceutical preparations, namely, RNA therapeutics for the treatment of pain; Pharmaceutical preparations, namely, RNA therapeutics for the treatment diseases of the central nervous system

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code005
First Use Anywhere DateMonday, October 2, 2023
First Use In Commerce DateMonday, October 2, 2023

Trademark Owner History


Party NameAtalanta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameAtalanta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NEW APPLICATION ENTERED
Wednesday, May 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 16, 2024ASSIGNED TO EXAMINER
Wednesday, November 6, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, August 16, 2024NON-FINAL ACTION E-MAILED
Friday, August 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 19, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 6, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED